Chronic Lymphocytic Leukemia - Aggressive Drug Combo Restores Quality Of Life Medical News Today FC in combination with rituximab, a monoclonal antibody drug, has proven to be the most effective therapy for extending life and has become the standard treatment for patients with CLL. Scientists were concerned that the FC-based treatment could have ... |
